Using dose-response characteristics of therapeutics agents for treatment decisions in type 2 diabetes.
about
Changing the treatment paradigm for type 2 diabetes.Current therapeutic options in type 2 diabetes mellitus: a practical approachComparison of nateglinide and gliclazide in combination with metformin, for treatment of patients with Type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone.Predictors of response in initial users of metformin and sulphonylurea derivatives: a systematic review.Use of oral combination therapy for type 2 diabetes in primary care: Meeting individualized patient goals.Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study.The effect of obesity on glycaemic response to metformin or sulphonylureas in Type 2 diabetes.Adding saxagliptin to extended-release metformin vs. uptitrating metformin dosage.
P2860
Q33610676-B07E6F9A-51EC-4E3C-80CE-8336E0CBBACBQ33723387-48F2C6C4-8092-4510-A22C-53A4888C670BQ35038326-A32D1156-E8C6-40AF-81F2-5624F9ABEEB7Q35541829-EADC04F0-DA95-4D59-B25D-578B66AC2FA6Q38599975-9F74FBEF-4719-4A4E-BFEA-19B73AF4519CQ46860931-4EC35327-F50D-4BEA-91C9-5EFE0E075B92Q46909172-981A8926-2D71-4315-90AA-ABAAA9466C09Q51363561-E18A580C-059C-436C-87CB-75850461052E
P2860
Using dose-response characteristics of therapeutics agents for treatment decisions in type 2 diabetes.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Using dose-response characteri ...... decisions in type 2 diabetes.
@ast
Using dose-response characteri ...... decisions in type 2 diabetes.
@en
Using dose-response characteri ...... decisions in type 2 diabetes.
@nl
type
label
Using dose-response characteri ...... decisions in type 2 diabetes.
@ast
Using dose-response characteri ...... decisions in type 2 diabetes.
@en
Using dose-response characteri ...... decisions in type 2 diabetes.
@nl
prefLabel
Using dose-response characteri ...... decisions in type 2 diabetes.
@ast
Using dose-response characteri ...... decisions in type 2 diabetes.
@en
Using dose-response characteri ...... decisions in type 2 diabetes.
@nl
P2860
P1476
Using dose-response characteri ...... decisions in type 2 diabetes.
@en
P2093
P2860
P304
P356
10.1046/J.1463-1326.2000.00054.X
P577
2000-06-01T00:00:00Z